IC50: 1.7 nM (Clk1)[1].
CLK1-IN-2 is metabolically stable Clk1 inhibitor. CLK1-IN-2 has selectivity for Clk1 with an IC50 value of 1.7 nM. CLK1-IN-2 can be used for the research of tumour, Duchenne's muscular dystrop and viral infections such as Not affected the proliferation of normal human cells such as fibroblasts.
[1]. Dalia S El-Gamil, et al. Discovery of novel 5-methoxybenzothiophene drazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity. Eur J Med Chem. 2022 Dec 15;247:115019.
















